Scientists at Australian cannabis company Dolce Cann Global have developed a number of strains which boast a mix of cannabinoids with much stronger anti-inflammatory properties than standard CBD. By merging beauty, science, technology, and proprietary cannabis strains, they aim to create products that use 'ultrasonic diffusion', 'magnetic misting' and other enhanced delivery systems to allow greater absorption and better penetration of the super-strength cannabinoids. Scientists are now working on testing using human-derived cell lines to analyse the bio-efficacy on seven key cannabis strains. It is estimated 1.2 billion people in the world suffer from medical conditions for which cannabis has shown to be of therapeutic value. "The opportunities are endless and Brits could see the first super strength cannabis mist via our Reduit beauty brand as early as January 2022."

Source: Daily Mirror December 21, 2020 15:47 UTC